• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever.

作者信息

Belia Marina, Papanikolaou Asimina, Skendros Panagiotis, Vassilakopoulos Theodoros P

机构信息

Department of Haematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Department of Pathology, Evangelismos General Hospital, Athens, Greece.

出版信息

Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022059. doi: 10.4084/MJHID.2022.059. eCollection 2022.

DOI:10.4084/MJHID.2022.059
PMID:35865403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9266698/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/5e86b87af7d4/mjhid-14-1-e2022059f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/42529f08d207/mjhid-14-1-e2022059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/ed121b8fff5c/mjhid-14-1-e2022059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/5e86b87af7d4/mjhid-14-1-e2022059f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/42529f08d207/mjhid-14-1-e2022059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/ed121b8fff5c/mjhid-14-1-e2022059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b32e/9266698/5e86b87af7d4/mjhid-14-1-e2022059f3.jpg

相似文献

1
Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever.一名患有家族性地中海热的患者出现结节性淋巴细胞为主型霍奇金淋巴瘤。
Mediterr J Hematol Infect Dis. 2022 Jul 1;14(1):e2022059. doi: 10.4084/MJHID.2022.059. eCollection 2022.
2
Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma.接受结节性淋巴细胞为主型霍奇金淋巴瘤治疗的患者家庭中血液系统恶性肿瘤的风险
Hered Cancer Clin Pract. 2021 Feb 9;19(1):17. doi: 10.1186/s13053-021-00175-0.
3
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.伴有CD30阳性淋巴细胞为主型（LP）细胞的结节性淋巴细胞为主型霍奇金淋巴瘤（NLPHL）。
J Hematop. 2011 Jul 23;4(3):175. doi: 10.1007/s12308-011-0104-x. eCollection 2011 Sep.
4
Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.结节性淋巴细胞为主型霍奇金淋巴瘤的免疫结构模式：病理及临床意义
Expert Rev Hematol. 2015 Apr;8(2):217-23. doi: 10.1586/17474086.2015.991388. Epub 2014 Dec 9.
5
High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma.家族性结节性淋巴细胞为主型霍奇金淋巴瘤发病风险高。
J Clin Oncol. 2013 Mar 1;31(7):938-43. doi: 10.1200/JCO.2012.43.5958. Epub 2013 Jan 2.
6
CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.CD20 阴性结节性淋巴细胞为主型霍奇金淋巴瘤：一家三级癌症中心的 20 年连续病例系列。
Arch Pathol Lab Med. 2021 Jun 1;145(6):753-758. doi: 10.5858/arpa.2020-0135-OA.
7
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?功能成像能否区分结节性淋巴细胞为主型霍奇金淋巴瘤与 T 细胞/组织细胞丰富型大 B 细胞淋巴瘤？
Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):392-7. doi: 10.1016/j.clml.2013.03.004. Epub 2013 Jun 15.
8
Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.具有类似富含T细胞/组织细胞的B细胞淋巴瘤结节的结节性淋巴细胞为主型霍奇金淋巴瘤：结节性淋巴细胞为主型霍奇金淋巴瘤与富含T细胞/组织细胞的B细胞淋巴瘤的鉴别诊断
Blood. 2003 Nov 15;102(10):3753-8. doi: 10.1182/blood-2003-02-0626. Epub 2003 Jul 24.
9
Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.流式细胞术检测双阳性（CD4+CD8+）/PD-1bright T 细胞亚群有助于诊断结节性淋巴细胞为主型霍奇金淋巴瘤。
Arch Pathol Lab Med. 2022 Jun 1;146(6):718-726. doi: 10.5858/arpa.2020-0726-OA.
10
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.程序性死亡蛋白1（PD-1），一种有助于识别结节性淋巴细胞为主型霍奇金淋巴瘤的滤泡性T细胞标志物。
Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.

本文引用的文献

1
Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry.秋水仙碱抵抗的儿科 FMF 患者的抗 IL-1 治疗：HELIOS 注册研究的真实数据。
Rheumatology (Oxford). 2020 Nov 1;59(11):3324-3329. doi: 10.1093/rheumatology/keaa121.
2
Malignancies in systemic lupus erythematosus: an update.系统性红斑狼疮中的恶性肿瘤：最新进展。
Curr Opin Rheumatol. 2019 Nov;31(6):678-681. doi: 10.1097/BOR.0000000000000648.
3
Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans.
家族性地中海热：评估总体临床影响并制定治疗方案。
Mediterr J Hematol Infect Dis. 2019 May 1;11(1):e2019027. doi: 10.4084/MJHID.2019.027. eCollection 2019.
4
Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report.一名患有家族性地中海热和霍奇金淋巴瘤患者的系统性淀粉样变性：病例报告
J Pediatr Hematol Oncol. 2020 Apr;42(3):234-237. doi: 10.1097/MPH.0000000000001504.
5
Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients.卡那奴单抗治疗儿童家族性地中海热患者的长期疗效和安全性。
Mod Rheumatol. 2020 Jan;30(1):166-171. doi: 10.1080/14397595.2018.1559488. Epub 2019 Nov 21.
6
Familial Mediterranean Fever Is Commonly Diagnosed in Children in Israel with Periodic Fever Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome.家族性地中海热在以色列常被诊断为周期性发热、口疮性口炎、咽炎和淋巴结炎综合征的儿童。
J Pediatr. 2019 Jan;204:270-274. doi: 10.1016/j.jpeds.2018.08.080. Epub 2018 Oct 22.
7
On demand use of anakinra for attacks of familial Mediterranean fever (FMF).按需使用阿那白滞素治疗家族性地中海热（FMF）发作。
Clin Rheumatol. 2019 Feb;38(2):577-581. doi: 10.1007/s10067-018-4230-z. Epub 2018 Jul 30.
8
Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma.一名患有家族性地中海热和霍奇金淋巴瘤的儿童的化疗与秋水仙碱相互作用
Mediterr J Hematol Infect Dis. 2018 Mar 1;10(1):e2018019. doi: 10.4084/MJHID.2018.019. eCollection 2018.
9
Familial Mediterranean Fever and Incidence of Cancer: An Analysis of 8,534 Israeli Patients With 258,803 Person-Years.家族性地中海热与癌症发病风险：8534 例以色列患者和 258803 人年的分析。
Arthritis Rheumatol. 2018 Jan;70(1):127-133. doi: 10.1002/art.40344. Epub 2017 Dec 7.
10
Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.家族性地中海热患者亚临床炎症的评估：与突变类型和发作状态的关系：一项回顾性研究。
Clin Rheumatol. 2016 Nov;35(11):2757-2763. doi: 10.1007/s10067-016-3275-0. Epub 2016 Apr 23.